Pillstats
Rx only · Injection, Solution · Intramuscular

Lorazepam

Lorazepam

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05BA06
RxCUI (US)6470
US makers2 labelers
Packages2
DEA / ScheduleCIV

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.6K3.2K4.7K6.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.3K
Rx · 2026 Q1
1.5K
Units dispensed
-77%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 3, 2018
    SHORTAGEDrug shortage: Lorazepam Injection (Hospira, Inc., a Pfizer Company)

    Lorazepam Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Neurology.